home All News open_in_new Full Article
Appili Therapeutics Announces Submission of U.S. Federal Government Funding Proposals and Provides Corporate and Aditxt Transaction Update
Appili Therapeutics submitted four U.S. federal funding proposals totaling US$117.5 million for infectious disease treatment development. Modifications were received for the U.S. Air Force Academy Cooperative Agreement. The deadline for the Aditxt going-private transaction was extended to March 31, 2025.
today 24 h. ago attach_file Politics
attach_file
Politics
attach_file
Politics
attach_file
Politics
attach_file
Economics
attach_file
Politics
attach_file
Economics
attach_file
Economics
4 d. ago
Jordan’s Principle ‘not a suggestion,’ AMC grand chief says in call for full implementation
attach_file
Other
attach_file
Society
attach_file
Events
attach_file
Economics
attach_file
Economics
attach_file
Other
attach_file
Economics
attach_file
Economics
attach_file
Economics
ID: 1667837019